Medpace Holdings, Inc. (MEDP)

Accolade Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	2,232	2,109	1,886	1,460	1,142	925.93
Revenue Growth (YoY)	9.94%	11.84%	29.17%	27.80%	23.38%	7.54%
Cost of Revenue	702.7	682.1	638.25	534.89	441.09	354.43
Gross Profit	1,529	1,427	1,248	925.11	701.29	571.5
Selling, General & Admin	199.21	180.18	161.35	131.4	108.42	92.16
Other Operating Expenses	823.4	770.65	723.09	492.67	373.13	292.77
Operating Expenses	1,052	980.09	910.77	646.41	502.67	404.46
Operating Income	477.51	446.87	336.83	278.7	198.62	167.04
Interest Expense	-	-	-0.49	-2.91	-0.11	-
Interest & Investment Income	22.95	25	-	-	-	0.31
Currency Exchange Gain (Loss)	-0.5	-0.5	-1.93	3.86	2.78	0.51
Other Non Operating Income (Expenses)	-4.6	4.55	1.27	3.21	0.56	0.67
EBT Excluding Unusual Items	495.37	475.92	335.68	282.86	201.85	168.53
Pretax Income	495.37	475.92	335.68	282.86	201.85	168.53
Income Tax Expense	77.07	71.54	52.87	37.49	20	23.15
Net Income	418.3	404.39	282.81	245.37	181.85	145.38
Preferred Dividends & Other Adjustments	0	0.04	0.19	0.16	0.46	0.46
Net Income to Common	418.3	404.34	282.62	245.21	181.39	144.93
Net Income Growth	23.11%	42.99%	15.26%	34.93%	25.08%	44.74%
Shares Outstanding (Basic)	30	31	31	32	36	36
Shares Outstanding (Diluted)	31	32	32	34	38	38
Shares Change (YoY)	-2.69%	0.54%	-5.44%	-10.68%	-0.03%	0.35%
EPS (Basic)	13.83	13.06	9.20	7.57	5.06	4.07
EPS (Diluted)	13.46	12.63	8.88	7.28	4.81	3.84
EPS Growth	26.42%	42.23%	21.98%	51.35%	25.26%	43.82%
Free Cash Flow	579.82	572.27	396.73	351.17	235.06	227.34
Free Cash Flow Per Share	18.66	17.88	12.46	10.43	6.24	6.03
Gross Margin	68.51%	67.66%	66.16%	63.36%	61.39%	61.72%
Operating Margin	21.40%	21.19%	17.86%	19.09%	17.39%	18.04%
Profit Margin	18.74%	19.17%	14.99%	16.79%	15.88%	15.65%
Free Cash Flow Margin	25.98%	27.13%	21.04%	24.05%	20.58%	24.55%
EBITDA	506.48	476.12	363.15	301.04	219.73	186.57
EBITDA Margin	22.69%	22.57%	19.26%	20.62%	19.23%	20.15%
D&A For EBITDA	28.97	29.25	26.33	22.34	21.12	19.53
EBIT	477.51	446.87	336.83	278.7	198.62	167.04
EBIT Margin	21.40%	21.19%	17.86%	19.09%	17.39%	18.04%
Effective Tax Rate	15.56%	15.03%	15.75%	13.26%	9.91%	13.73%
Advertising Expenses	-	1.5	1.5	1.3	1.2	0.7

Updated Jul 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q